The effects of lycopene supplementation on serum insulin-like growth factor 1 (IGF-1) levels and cardiovascular disease: A dose-response meta-analysis of clinical trials.
CONCLUSION: Overall, lycopene intake was not associated with reduced serum IGF-1 levels. However, association was significant when lycopene was administrated at doses >15 mg/d, for < 12 weeks, as well as for healthy conditions and patients aged ≥60 years. In addition, lycopene supplementation exhibited potential health benefits in the management of patients with cardiac disorders.
PMID: 33259908 [PubMed - as supplied by publisher]
Source: Complementary Therapies in Medicine - Category: Complementary Medicine Authors: Xie Z, Yang F Tags: Complement Ther Med Source Type: research
More News: Alternative and Complementary Therapies | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Complementary Medicine | Databases & Libraries | Heart | Insulin | Lycopene | Science | Study